title: Stereotactic Body Radiotherapy (SBRT) for primary and recurrent head and neck tumors.
abstract: Stereotactic Body Radiotherapy (SBRT) is increasingly used to treat a variety of head and neck tumors as a result of its highly conformal dose distributions and stereotactic spatial accuracy in delivery. Our experience and other previous reports have shown that SBRT is technically feasible, well-tolerated and compares favorably to other alternatives of salvage therapy in the management of patients with recurrent and/or previously irradiated head and neck cancers. Furthermore, it has the advantage of a shorter treatment schedule, greater compliance, and safe delivery in the outpatient setting. This affords an opportunity to introduce SBRT as a definitive treatment in select patients. This review presents an overview of the use of SBRT for managing head and neck tumors by highlighting the existing indications and the expanding role of SBRT in managing these patients.
authors: Department of Otolaryngology, University of Pittsburgh Medical Center, PA, USA.
authors: Chwee Ming
authors: CM
authors: Lim
authors: David A
authors: DA
authors: Clump
authors: Dwight E
authors: DE
authors: Heron
authors: Robert L
authors: RL
authors: Ferris
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000601:surgery; D006258:Head and Neck Neoplasms / Q000601:surgery*; D006801:Humans; D064847:Multimodal Imaging; D009364:Neoplasm Recurrence, Local / Q000601:surgery*; D010349:Patient Compliance; D049268:Positron-Emission Tomography; D016634:Radiosurgery / Q000295:instrumentation / Q000379:methods*; D011879:Radiotherapy Dosage; D020266:Radiotherapy, Conformal; D012449:Safety; D016879:Salvage Therapy; D014057:Tomography, X-Ray Computed